Results 211 to 220 of about 146,987 (295)

Targeting IL27RA Enhances Immunotherapy in Triple‐Negative Breast Cancer by Modulating Tumor Cells and the Tumor Microenvironment

open access: yesAdvanced Science, EarlyView.
IL27RA upregulation drives immune evasion in TNBC by suppressing MHC‐I expression and reprogramming T/NK‐cell states, establishing an immune‐excluded tumor phenotype. Targeting this epithelial‐intrinsic IL27RA–PI3K/AKT axis offers a promising strategy to overcome immunotherapy resistance.
Jiachi Xu   +8 more
wiley   +1 more source

Recent Updates on PRDM2 in Colorectal Cancer

open access: yesFrontiers in Bioscience-Landmark
Erika Di Zazzo   +4 more
doaj   +1 more source

High expression of TRMT112 is associated with the development of oral squamous cell carcinoma. [PDF]

open access: yesJ Oral Biol Craniofac Res
Pandi A   +3 more
europepmc   +1 more source

73P TROP2 amplification is highly present in dedifferentiated liposarcoma: Data from the Cancer Genome Atlas (TCGA) in soft tissue sarcoma [PDF]

open access: gold
Sonia Maria Orlando   +8 more
openalex   +1 more source

Core Fucosylation Represses SMURF1‐Dependent Degradation of CD47 to Promote Tumor Immune Evasion

open access: yesAdvanced Science, EarlyView.
FUT8‐mediated core fucosylation of CD47 at N111 blocks SMURF1 binding and reduces CD47 ubiquitination and degradation. Blocking N111 glycosylation reduces CD47 expression and promotes macrophage phagocytosis of tumor cells. Furthermore, ablating CD47 core fucosylation boosts CD103+ dendritic cells (DCs) infiltration, increases natural killer (NK) cell ...
Yuting Cao   +8 more
wiley   +1 more source

TCGA data reveal a highly heterogeneous disease [PDF]

open access: yesNature Reviews Clinical Oncology, 2017
openaire   +1 more source

Home - About - Disclaimer - Privacy